Biotech Essentials

Career and Jobs

Biotech Career and Jobs Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 07.10.2021.

#biotech
#TRIPSWaiver
#omics
#bioinformatics
#science
#CIO
#researchlife
#BIOIMPACT
#startups
#GoodDayBIO

Career And Jobs

@biospace shared
On Oct 5, 2021
SPACs offer efficiency and flexibility for biopharma startups. Will the trend last? #startups #biotech https://t.co/np8HMainxi
Open
SPACs Offer Efficiency and Flexibility for Biopharma Startups. Will the Trend Last?

SPACs Offer Efficiency and Flexibility for Biopharma Startups. Will the Trend Last?

Wanting to find out what is fueling the trend, BioSpace solicited the perspectives of a couple of executives who chose the SPAC route.

@MassBioEd shared
On Oct 5, 2021
RT @SChapley: I was surprised and excited to be recognized for a career I enjoy thank you @MassBioEd https://t.co/QdndhYVgM1
Open
Frontier instructor named Biotechnology Teacher of the Year

Frontier instructor named Biotechnology Teacher of the Year

SOUTH DEERFIELD — The lack of a dedicated biotechnology program at Frontier Regional School doesn’t stop Stacey Chapley from incorporating it into her curriculum. It also didn’t stop her ...

@GENbio shared
On Oct 4, 2021
RT @SnthesisInc: Incredible article here about Data Integration and Harmonization! Nice work @GENbio. Oh yeah, the article just happens to be about Snthesis! #bioinformatics #science #omics #researchlife #CIO https://t.co/l8Idp3okce
Open
Biopharma Can Dispel the Fog of Data

Biopharma Can Dispel the Fog of Data

Snthesis describes how data can be aggregated, connected, and harmonized to optimize workflows and reveal scientific insights.

@IAmBiotech shared
On Oct 6, 2021
#GoodDayBIO: Recap of #BIOIMPACT, including insights on how we can calculate the benefits of #sustainability practices and ensure they can be widely adopted. Plus, an update on the #TRIPSWaiver. https://t.co/wLRqHEC8hj
Open
Good Day BIO: Calculating the climate benefits of biotech – and a TRIPS update

Good Day BIO: Calculating the climate benefits of biotech – and a TRIPS update

How can we calculate the benefits of our sustainability practices—and ensure biotech innovations can be widely adopted? Experts provided insight during BIO IMPACT yesterday. We also have an ...

@biospace shared
On Oct 1, 2021
Philadelphia bursting at the seams as biopharma hub status grows #biopharma #industrygrowth https://t.co/riRwPLuSpA
Open
Philadelphia Bursting at the Seams as Biopharma Hub Status Grows

Philadelphia Bursting at the Seams as Biopharma Hub Status Grows

As the city rapidly develops as a biopharma hub, wet lab space is rapidly dwindling.

@CALifeSciences shared
On Oct 4, 2021
Come work with us! We’re hiring a Business Development Manager in the #BayArea. Learn more, apply or share the job description here: https://t.co/i8zmb8aQuv https://t.co/WClDhx0ITP
Open
Manager, Business Development

Manager, Business Development

CLS JOB DESCRIPTION Job Title: Manager, Business Development Job Level: Manager Location: South San Francisco Supervisor: Director, Membership FLSA: Exempt Travel: Up to 50% Local Travel ...

@GENbio shared
On Oct 5, 2021
RT @SangamoTx: Our CEO, Sandy Macrae, shares his hopes for the future of #biotech in @GENbio's special 40th anniversary issue! Click here to read more: https://t.co/HKqsnNiRbz
Open
40th Anniversary Recollections & Predictions

40th Anniversary Recollections & Predictions

To help celebrate GEN’s 40th Anniversary with this special October issue, we asked scientists and business professionals in academia and industry to give us their reflections, impressions, ...

@MassBio shared
On Oct 1, 2021
For our October #MemberSpotlight, we spoke with Sekar Kathiresan, M.D., Co-Founder & CEO, @VerveTx. Read the full Spotlight to learn how Verve is pioneering #GeneEditing medicines to treat patients with cardiovascular disease https://t.co/BYfWsN5izf
Open
Member Spotlight: Q&A with Verve Therapeutics

Member Spotlight: Q&A with Verve Therapeutics

In October, we spoke with Sekar Kathiresan, M.D., Co-Founder and CEO, Verve Therapeutics, a biotechnology company pioneering a new approach to the care of cardiovascular disease, ...